One of the most egregious outcomes of marijuana prohibition is that many sick people cannot legally access the medicine that works best for them. For many seriously ill people, medical marijuana is the only medicine that relieves their pain and suffering, or treats symptoms of their medical condition, without debilitating side effects. Marijuana has been shown to alleviate symptoms of a huge variety of serious medical conditions including cancer, AIDS, and glaucoma, and is often an effective alternative to synthetic painkillers.
Medical Marijuana Access and Research
Twenty-one states and the District of Columbia have passed medical marijuana laws legalizing the use and production of medical marijuana for qualifying patients under state law. However, the medical use of marijuana remains illegal under federal law, and patients in the remaining states are without any legal access at all. Even in states where medical marijuana laws exist, patients and providers are vulnerable to arrest and interference from federal law enforcement.
Marijuana prohibition has also thwarted research within the United States to uncover the best and most effective uses for marijuana as a medicine, making efforts to reform medical marijuana laws particularly difficult.
DPA played a primary role in the passage of medical marijuana laws in nine states, starting with California’s Proposition 215
in 1996. We seek to implement medical marijuana programs in additional states and to expand existing programs to better protect patients’ rights and to improve patient access to their medicine.
The Drug Policy Alliance is committed to increasing the number of states with medical marijuana laws, supporting and improving existing state medical marijuana programs, protecting medical marijuana patients, and ending the federal ban on medical marijuana
so that all patients within the United States have safe access to quality medicine and research into marijuana’s medicinal benefits can move forward.
Legislation a Reaction to Department of Justice's Interference with State-authorized Medical Marijuana Programs
Medical Marijuana Patients, Medical Providers and Caregivers Seeking Protection from Overreaching by Federal Government
Three important bi-partisan bills pertaining to state-authorized medical marijuana programs were introduced in Congress today, by three different Members of Congress. The legislation sends a clear signal to US Attorneys, the Department of Justice, and the DEA to stop trying to undermine state laws designed to provide cancer, AIDS and other medical marijuana patients with safe and legal access to their medicine.
DPA Executive Director Ethan Nadelmann talks about the latest developments in the world of medical marijuana in the US and President Obama's difficulties keeping his campaign promises and word as President to not interfere with medical marijuana dispensaries in states that have approved medical marijuana law.
This is the third update from DPA's No More Drug War campaign.
Patients and Families Accuse State Officials of Playing Politics with Medical Marijuana Program
Trenton—A letter sent by New Jersey Attorney General Paula Dow to U.S. Attorney General Eric Holder regarding New Jersey's fledgling medical marijuana program is drawing sharp criticism from medical marijuana supporters, including patients and families who advocated for the law.
This helpful resource is frequently updated with medical marijuana legislation pending in the states.
Legislators appreciate hearing from their constituents, and they are elected to represent our views. Always give your legislator your name, address, and telephone number so that they know you are one of their constituents. Be sure to include this information whether you visit in person, call, or write.
When you contact your legislators, a short sentence or two about why you personally support or oppose a certain proposal is fine.
Most importantly, always be courteous and clear when communicating with your legislators. Remember, legislators are people, too!
Center for Medicinal Cannabis Research, University of California
This report was submitted in response to the California legislature passing and Governor Gray Davis signing SB847, which commissioned the University of California to establish a scientific research program to expand the public scientific knowledge on purported therapeutic usages of marijuana.
The acceptance of medical marijuana has implications that extend far beyond helping those suffering from life-threatening diseases. It is one of several factors -- including demographic changes, the financial crisis, and the widely perceived failure of the war on drugs -- reopening the country's 40-year-old on-again, off-again shouting match over whether marijuana should be legalized.
In 1996 DPA spearheaded passage of the nation’s first medical marijuana law. California’s Proposition 215, the Compassionate Use Act, allows patients to use marijuana for medicinal purposes with a doctor’s recommendation. Despite the federal government’s efforts to stymie Prop. 215 by threatening and shutting down dispensaries, over a dozen other states have legalized medical marijuana since 1996, many of them due to DPA’s efforts.
The principle issue here is whether the marijuana plant should lawfully be transferred from Schedule I to Schedule II of the schedules established by the Controlled Substances Act. Ruling of Drug Enforcement Administration Administrative Law Judge Francis L. Young, "In the Matter of Marijuana Rescheduling," finding that: "Marijuana, in its natural form, is one of the safest therapeutically active substances known to man. By any measure of rational analysis marijuana can be safely used within a supervised routine of medical care."